CLINICAL_TRIALS ClinicalTrials.gov record update

Haemo-autologous Antegrade Repriming (HAR) Clinical Trial for Validation as Minimum Impact Perfusion Strategy in Cardiopulmonary Bypass

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03720184
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:49.507680+00:00
Published At: 2021-02-12T00:00:00+00:00
Record Updated At: 2021-02-12
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Anemia", "Cognitive; Disorder, Due to General Medical Condition", "Embolism, Air", "Transfusion", "Cardiac Disease", "Extracorporeal Circulation; Complications", "Valve Anomalies"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-02-12"
protocolSection.identificationModule.nctId: "NCT03720184"
protocolSection.identificationModule.officialTitle: "Haemo-autologous Antegrade Repriming (HAR) Clinical Trial for Validation as Minimum Impact Perfusion Strategy in Cardiopulmonary Bypass"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.